Opportunity
Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R33- Clinical Trial Required)
- Agency
- National Institutes of Health
- Number
- PAR-25-183
- Opens
- Nov 26, 2024
- Closes
- Oct 15, 2027
- Status
- posted
- Source
- View the official announcement →
GrantPing organises and filters this listing. The official announcement is the authoritative record — check it for eligibility and full requirements.
Get these before the deadline
GrantPing emails you only the opportunities that match your keywords, soonest close date first. Free weekly digest, no account needed.
Get alertsMore from National Institutes of Health
- Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access… closes 2026-10-30
- GREGoRi Technology Integration Center (U01, Clinical Trials Optional) closes 2026-10-30
- GREGoRi Innovation Projects (U01 Clinical Trial Optional) closes 2026-10-30
- GREGoRi Data Coordination and Outreach Center (U01, Clinical Trials Not Allowed) closes 2026-10-30
- HEAL Initiative: Whole Joint Health Program (R61/R33 Clinical Trial Required) closes 2026-10-30
- Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin… closes 2026-11-02